XML 15 R1.htm IDEA: XBRL DOCUMENT v3.25.4
Cover
 12 Months Ended
Jun. 30, 2025
shares
Entity Addresses [Line Items]  
Document Type 20-F/A
Amendment Flag true
Amendment Description Basel Medical Group Ltd (the “Company”) is filing this Amendment No. 1 (“Amendment”) to its Annual Report on Form 20-F for the fiscal year ended June 30, 2025, as initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 18, 2025 (the “Initial Filing”), for the purpose of amending and restating the sections “Item 3. Key Information—D. Risk Factors”, “Item 4. Information on the Company—A. History and Development of the Company”, “Item 4. Information on the Company—B. Business Overview”, “Item 4. Information on the Company—C. Organizational Structure”, “Item 5. Operating and Financial Review and Prospects”, “Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions”, “Item 16C. Principal Accountant Fees and Services”, to refile a new report of the independent registered public accounting firm NLA DFK Assurance PAC to its audited consolidated financial statements for the years ended June 30, 2024 and 2025, and to amend and restate its audited consolidated financial statements for the years ended June 30, 2024 and 2025 and the notes thereto. As required by Rule 12b-15 of the Securities and Exchange Act of 1934, as amended, the Company is filing or furnishing the certifications required under Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002 as exhibits to this Amendment, and is also refiling its exhibit 8.1 to amend and restate its list of subsidiaries as of March 13, 2026.  
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Jun. 30, 2025
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2025
Current Fiscal Year End Date --06-30
Entity File Number 001-42527
Entity Registrant Name Basel Medical Group Ltd
Entity Central Index Key 0002004489
Entity Incorporation, State or Country Code D8
Entity Address, Address Line One 6 Napier Road
Entity Address, Address Line Two Unit #02-10/11 Gleneagles Medical Centre
Entity Address, City or Town Singapore
Entity Address, Country SG
Entity Address, Postal Zip Code 258499
Title of 12(b) Security Ordinary shares with no par value
Trading Symbol BMGL
Security Exchange Name NASDAQ
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Entity Common Stock, Shares Outstanding 18,785,750
ICFR Auditor Attestation Flag false
Document Financial Statement Error Correction [Flag] true
Document Financial Statement Restatement Recovery Analysis [Flag] false
Auditor Name NLA DFK Assurance PAC
Auditor Location Singapore
Auditor Firm ID 6889
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One 6 Napier Road
Entity Address, Address Line Two Unit #02-10/11 Gleneagles Medical Centre
Entity Address, City or Town Singapore
Entity Address, Country SG
Entity Address, Postal Zip Code 258499
Contact Personnel Name Dr. Darren Yen Feng Chhoa
Contact Personnel Email Address contact@baselmedical.com